Strong TripleTOF 5600 Sales Drive Mid-Teens Q2 Growth at AB Sciex
July 22, 2011
Strong TripleTOF 5600 Sales Drive Mid-Teens Q2 Growth at AB Sciex
Saying that the 5600 "has exceeded expectations," Danaher president and CEO Larry Culp suggested that in the first half of the year AB Sciex "probably took a little bit of share in certain corners" of the mass spec market.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- BGI Aims to Expand Proteomics Services, Purchase 50-Plus New Mass Spectrometers
June 17, 2011 / ProteoMonitor - Strong Demand for Triple-TOF 5600 Drives AB Sciex's Q1 Revenue Growth
April 22, 2011 / ProteoMonitor - High-End Mass Spec Sales Drive Double-Digit Q4 Growth at Waters, AB Sciex
January 28, 2011 / ProteoMonitor - Instrument Vendors Focus on UPLC and Triple-Quad, Qual-Quan MS at JP Morgan Conference
January 14, 2011 / ProteoMonitor - Major Mass Spec Vendors Highlight New Offerings at UBS Global Life Sciences Conference
September 24, 2010 / ProteoMonitor